Erectile dysfunction devices market set for faster growth through 2030

The erectile dysfunction devices market is projected to rise from $2.09 billion in 2025 to $3.73 billion by 2030, driven by diabetes, cardiovascular disease, aging, and broader access to care. North America leads today, but Asia-Pacific is expected to be the fastest-growing region as demand shifts toward non-invasive and at-home treatment options.

Why it matters: - Erectile dysfunction devices are gaining traction as more men seek treatment options that can restore sexual function and quality of life. - Demand is rising alongside prostate cancer treatment, where erectile dysfunction is a common side effect. - The market is also being shaped by aging populations, chronic disease, and growing acceptance of medical devices for sexual wellness.

What happened: - The Business Research Company released an outlook on the erectile dysfunction devices market on August 6, 2026. - The market is estimated at $2.09 billion in 2025 and is forecast to reach $2.35 billion in 2026. - The report projects the market will grow to $3.73 billion by 2030, at a 12.3% compound annual growth rate. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing regional market over the next several years.

The details: - The market’s recent growth has been driven by diabetes, cardiovascular disease, an aging male population, greater awareness of erectile dysfunction treatments, and wider access to urology care. - Future growth is expected to come from lifestyle-related disorders, higher male health awareness, broader acceptance of medical devices for sexual wellness, expanded access to minimally invasive treatments, and better healthcare infrastructure in emerging economies. - Key product trends include non-invasive erectile dysfunction devices, at-home management, vacuum erection devices and penile pumps, surgical penile implants for severe cases, and more personalized treatment approaches. - Erectile dysfunction devices are medical aids that help men achieve and sustain erections through suction, pressure constriction, medication delivery, or structural support. - The report says the market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. - The company’s 2026 market reports include market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, and updated graphics and tables. - The company offers a free sample of the report and a full version through its website: Download a free sample and View the full report.

Between the lines: - Prostate cancer is emerging as a key demand driver because treatment can damage erectile function and increase the need for recovery tools. - The report links rising prostate cancer incidence to aging, improved screening, and lifestyle changes. - The American Cancer Society projected about 313,780 new U.S. prostate cancer cases in September 2025. - The same source said prostate cancer risk rises from 0.2% in men under 50 to 6.5% in men ages 70 to 79. - The market’s shift toward home-based and non-invasive options suggests patients and providers are favoring less invasive sexual health care.

What's next: - The market is expected to keep expanding through 2030 as treatment access improves and more men seek discreet, at-home solutions. - Demand for vacuum erection devices, penile pumps, and surgical implants is expected to increase as treatment needs vary by severity. - Growth in emerging economies could accelerate as healthcare infrastructure and urology access improve.

The bottom line: - Erectile dysfunction devices are moving from a niche treatment category to a broader sexual health market with strong growth potential across regions and patient groups.